Prevention of no-reflow in acute myocardial infarction patients who received primary percutaneous coronary intervention with routine Ⅱb /Ⅲa receptor antagonist associated with thrombus aspiration

ZHANG Bi-li,CHEN Xiang,XU Rong-liang,QIN Yong-wen,ZHENG Xing,HU Jian-qiang,MA Li-ping,WU Hong,CHEN Shao-ping,CHEN Feng,ZHAO Xian-xian

DOI: https://doi.org/10.3969/j.issn.1004-8812.2013.02.004

2013-01-01

Abstract:Objective To evaluate the effect of optimized primary percutaneous coronary intervention ( PCI) treatment strategies in acute myocardial infarction patients on reduction of intraoperative ″ no-reflow phenomenon″. Methods 165 acute myocardial infarction patients who received primary PCI was enrolled from June 2011 to June 2012 in the department of cardiology of Changhai hospital. Patients was randomly assigned to a empirical treatment group ( n = 79,thrombectomy device and ( or) Ⅱb / Ⅲa receptor antagonist was used only when thrombus burden was heavy) or a optimized treatment group ( n = 86,Ⅱb / Ⅲ a receptor antagonist and thrombectomy device was used regardless of thrombus burden) . Incidence of no-reflow were observed during PCI in both groups. Results Intraoperative no-reflow rates during PCI in empirical treatment group and optimized treatment group were 14% and 1. 16% ,respectively,P < 0. 05. Bleeding complications did not increase in the optimized treatment group. Conclusions Optimized treatment strategies compared with empirical treatment strategies in acute myocardial infarction patients with primary PCI significantly reduced the incidence of no-reflow,and does not increase bleeding complications.